Project Number 1RF1AG057443-01 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Open systems for AMP-AD target enhancement Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Category G. Consortia and Public Private Partnerships 2. Public Private Partnership Researcher and Organization Principal Investigator MANGRAVITE, LARA M Principal Investigator First Name PAUL Principal Investigator Last Name BRENNAN Awardee Organization SAGE BIONETWORKS Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-17-054: Enhancing the Target and Biomarker Discovery Efforts of the AMP-AD and M2OVE-AD (R01) FY Overall Cost $3,390,271 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project
